Cost-Effectiveness of Bendamustine-Rituximab in First-Line Indolent NHL- A Patient-Level Simulation
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.530
https://www.valueinhealthjournal.com/article/S1098-3015(13)02435-2/fulltext
Title :
Cost-Effectiveness of Bendamustine-Rituximab in First-Line Indolent NHL- A Patient-Level Simulation
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02435-2&doi=10.1016/j.jval.2013.08.530
First page :
A415
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
511